Literature DB >> 17032716

Effectiveness of bone density measurement for predicting osteoporotic fractures in clinical practice.

William D Leslie1, James F Tsang, Patricia A Caetano, Lisa M Lix.   

Abstract

CONTEXT: Bone density measurement with dual-energy x-ray absorptiometry is widely used for fracture risk assessment. It has not been established that published gradients of fracture risk from study populations can be directly applied to clinical populations.
OBJECTIVE: The objective of the study was to assess osteoporotic fracture prediction with dual-energy x-ray absorptiometry in a large clinical cohort.
DESIGN: This was a historical cohort study (mean observation period 3.2 +/- 1.5 yr). PATIENTS: The study population was drawn from the population-based database of the Manitoba Bone Density Program. Analyses were limited to women aged 50 yr or older at baseline (n = 16,505). MAIN OUTCOME MEASURE: Each subject's longitudinal health service record was assessed for the presence of nontrauma fracture codes (hip, spine, wrist, and humerus) after bone density testing. Age-adjusted hazard ratios for fracture were derived from Cox proportional hazards models.
RESULTS: Site-specific and overall fracture rates were significantly associated with each site of bone density measurement (all P < 0.00001). The 95% confidence intervals overlapped those from a widely cited metaanalysis of fracture prediction from different sites. Although fracture prediction was not significantly different between the three hip measurement sites, each hip site was better than the lumbar spine for predicting overall fractures (nonoverlapping 95% confidence intervals). The manufacturer sd (equivalent to a unit change in T-score) resulted in a significantly smaller gradient of risk for the spine than when the population sd was used.
CONCLUSIONS: Bone density measurements are effective for predicting fractures in clinical practice. However, hip measurements were superior to the spine in overall osteoporotic fracture prediction.

Entities:  

Mesh:

Year:  2006        PMID: 17032716     DOI: 10.1210/jc.2006-1415

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  45 in total

Review 1.  Assessment of fracture risk.

Authors:  Sanford Baim; William D Leslie
Journal:  Curr Osteoporos Rep       Date:  2012-03       Impact factor: 5.096

2.  A comparative study of using non-hip bone density inputs with FRAX®.

Authors:  W D Leslie; L M Lix; H Johansson; A Oden; E McCloskey; J A Kanis
Journal:  Osteoporos Int       Date:  2011-10-19       Impact factor: 4.507

3.  High bone mineral density is associated with high body mass index.

Authors:  S Morin; W D Leslie
Journal:  Osteoporos Int       Date:  2008-11-26       Impact factor: 4.507

Review 4.  Osteoporosis prevention, screening, and treatment: a review.

Authors:  Juliana M Kling; Bart L Clarke; Nicole P Sandhu
Journal:  J Womens Health (Larchmt)       Date:  2014-04-25       Impact factor: 2.681

5.  Associations between adverse social position and bone mineral density in women aged 50 years or older: data from the Manitoba Bone Density Program.

Authors:  S L Brennan; W D Leslie; L M Lix
Journal:  Osteoporos Int       Date:  2013-02-22       Impact factor: 4.507

6.  Associations between serum vitamin E concentration and bone mineral density in the US elderly population.

Authors:  J Zhang; X Hu; J Zhang
Journal:  Osteoporos Int       Date:  2016-12-01       Impact factor: 4.507

7.  Factors associated with vertebral fractures in men treated with androgen deprivation therapy for prostate cancer.

Authors:  Philip J Saylor; Ronald A Morton; Michael L Hancock; K Gary Barnette; Mitchell S Steiner; Matthew R Smith
Journal:  J Urol       Date:  2011-06-15       Impact factor: 7.450

8.  Prediction of hip and other osteoporotic fractures from hip geometry in a large clinical cohort.

Authors:  W D Leslie; P S Pahlavan; J F Tsang; L M Lix
Journal:  Osteoporos Int       Date:  2009-02-24       Impact factor: 4.507

9.  Does diabetes modify the effect of FRAX risk factors for predicting major osteoporotic and hip fracture?

Authors:  W D Leslie; S N Morin; L M Lix; S R Majumdar
Journal:  Osteoporos Int       Date:  2014-08-05       Impact factor: 4.507

10.  Bone density in proton pump inhibitors users: a prospective study.

Authors:  Kamil Ozdil; Resul Kahraman; Abdurrahman Sahin; Turan Calhan; Erdem H Gozden; Umit Akyuz; Burak Erer; Mehmet H Sokmen
Journal:  Rheumatol Int       Date:  2013-03-02       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.